SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-11-020640
Filing Date
2011-03-01
Accepted
2011-03-01 16:07:41
Documents
14
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K y89208e10vk.htm 10-K 1917680
2 EX-21.1 y89208exv21w1.htm EX-21.1 32456
3 EX-23.1 y89208exv23w1.htm EX-23.1 6779
4 EX-31.1 y89208exv31w1.htm EX-31.1 9002
5 EX-31.2 y89208exv31w2.htm EX-31.2 9405
6 EX-32.1 y89208exv32w1.htm EX-32.1 3585
7 EX-32.2 y89208exv32w2.htm EX-32.2 3812
14 GRAPHIC y89208y8920801.gif GRAPHIC 10076
  Complete submission text file 0000950123-11-020640.txt   19171517

Data Files

Seq Description Document Type Size
8 EX-101 INSTANCE DOCUMENT celg-20101231.xml EX-101.INS 2476223
9 EX-101 SCHEMA DOCUMENT celg-20101231.xsd EX-101.SCH 141894
10 EX-101 CALCULATION LINKBASE DOCUMENT celg-20101231_cal.xml EX-101.CAL 123459
11 EX-101 LABELS LINKBASE DOCUMENT celg-20101231_lab.xml EX-101.LAB 1101094
12 EX-101 PRESENTATION LINKBASE DOCUMENT celg-20101231_pre.xml EX-101.PRE 696322
13 EX-101 DEFINITION LINKBASE DOCUMENT celg-20101231_def.xml EX-101.DEF 334143
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Filer) CIK: 0000816284 (see all company filings)

IRS No.: 222711928 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34912 | Film No.: 11651675
SIC: 2834 Pharmaceutical Preparations